Yingliang Wei

机构：Yunnan University, Shanghai Normal University, Luoyang Institute of Science and Technology, China Medical University · ORCID：0000-0001-6714-4293

发表论文 71 篇 · 总被引 1474 次 · h-index 20

代表论文

• PGC-1α in osteoarthritic chondrocytes: From mechanism to target of action (2023 · Frontiers in Pharmacology · 被引 22)
• Natural anti‐inflammatory products for osteoarthritis: From molecular mechanism to drug delivery systems and clinical trials (2023 · Phytotherapy Research · 被引 14)
• Hydrogel-Based Microspheres for Intra-Articular Osteoarthritis Therapy: Multifunctional Carriers for Drug Delivery and Cartilage Repair: A Comprehensive Review (2025 · International Journal of Nanomedicine · 被引 12)
• Serum trace elements and osteoarthritis: A meta-analysis and Mendelian randomization study (2024 · Journal of Trace Elements in Medicine and Biology · 被引 10)
• Ultra-processed food consumption, genetic susceptibility, and the risk of hip/knee osteoarthritis (2024 · Clinical Nutrition · 被引 9)
• MK8722 alleviates osteoarthritis by activating Sesn2 and transcriptionally upregulating BNIP3 to promote mitophagy and inhibit chondrocyte ferroptosis (2025 · Journal of Advanced Research · 被引 7)